Gene Query: ATG2B

Dataset Description Geneva Score
HNF1 regulates critical functions of the human epididymis epithelium. 33.82
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 33.82
The regulartory role of ZCCHC24 in splicing machinery 24.29
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 22.18
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 21.27
LNCaP treated with iBET 20.73
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 19.82
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 18.94
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 18.67
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 18.43
Expression data from miR340 overexpressing human A549 cells 18.0
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 16.62
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 15.92
Impact of dieldrin on transcription in Jurkat T cells 15.82
R430: A potent inbibitor of DNA and RNA viruses 15.16
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 15.06
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 14.28
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 13.65
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 13.64
Differential analysis of gene regulation at transcript resolution by RNA-Seq 13.4
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 13.4
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 13.17
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 13.15
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 13.0
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 12.98
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 12.17
MeRIP-seq for heat shock in B-cell lymphoma cells 11.78
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 11.57
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 11.34
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 11.34
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 11.34
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 11.17
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 11.17
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 11.09
Identification of long noncoding RNAs regulated by p53 11.05
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 10.87
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 10.85
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 10.66
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.65
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 10.63
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 10.61
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 10.55
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 10.35
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.2
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.2
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 10.13
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 10.13
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 10.12
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 10.04
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 9.97
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 9.8
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 9.79
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 9.79
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.74
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.69
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 9.65
Oncogenic MYC induces a dependency on the spliceosome in human cancer 9.45
TGF-β regulation of miRNA expression in pancreatic cancer 9.43
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 9.2
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 9.16
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.07
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.07
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 8.93
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 8.82
RNA-sequencing of human liver tissue 8.79
Lysine benzoylation is a novel histone mark [RNA-seq] 8.78
Lysine benzoylation is a novel histone mark 8.78
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 8.74
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 8.66
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 8.56
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 8.47
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 8.41
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.4
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.38
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 8.36
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 8.19
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 8.16
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 8.15
RNA-sequencing in irradiated and normal A549 cells. 8.14
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 7.97
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 7.96
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 7.9
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 7.82
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.75
Gene expression profiling of leukemia cells following asparagine depletion 7.74
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.72
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 7.62
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 7.61
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.58
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.57
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.49
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.47
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 7.4
TFAP2C signalling in human fibroblasts 7.22
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 7.22
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 7.22
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 7.19
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 7.18
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.14
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 7.14
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 7.12
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 7.09
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.03
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.98
Global Mapping of Human RNA-RNA Interactions 6.97
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 6.95
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.9
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 6.88
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 6.87
6.86
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.83
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 6.83
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 6.82
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.79
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 6.74
Genome wide expression change in LCC2 and MCF-7 cells 6.73
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 6.72
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.71
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.65
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.65
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.62
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 6.56
LIN28A modulates splicing and gene expression programs in breast cancer cells 6.56
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.52
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 6.48
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 6.48
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.47
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.47
Selective suppression of endothelial cytokine production by progesterone receptor 6.45
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 6.45
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 6.43
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 6.42
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.41
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 6.38
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 6.34
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 6.34
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.34
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 6.32
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.31
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 6.29
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 6.29
Nucleoporin-mediated regulation of cell identity genes 6.28
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 6.18
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.17
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.15
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.14
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 6.14
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 6.14
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 6.12
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 6.11
The role of FAM46C in myeloma cells 6.11
The role of FAM46C in myeloma cells [sequencing] 6.11
DART-seq: an antibody-free method for global m6A detection 6.1
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 6.04
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.98
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 5.95
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.94
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.93
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 5.9
Region-specific Innate Antiviral Responses of the Human Epididymis 5.84
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.8
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 5.8
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.76
Gene expression profile in breast cancer cells 5.76
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 5.75
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 5.74
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 5.74
Co-regulation of splicing by Rbfox1 and hnRNP M 5.74
Genome-wide analysis of the Integrator complex 5.74
Genome-wide analysis of the Integrator complex (HTS) 5.74
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.74
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.74
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 5.68
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.67
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 5.63
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 5.62
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 5.62
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.61
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 5.58
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 5.58
Gene expression in GBM with Cav3.2 inhibition 5.56
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 5.55
MYC dependent mRNA translation shapes gene expression and cell biology 5.55
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 5.46
Transcriptomic analyssis following EHMT1/2 inhibition 5.46
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.45
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.42
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 5.42
Transcriptomic profiling of human peripheral blood-derived mast cells 5.38
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.38
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 5.36
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 5.35
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.35
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.34
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 5.31
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 5.3
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.3
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.23
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 5.23
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 5.23
Role for citron kinase in prostate cancer growth 5.2
Stem and effector CD8 T-cells from human cancers 5.19
RNA sequencing analysis of selumetinib-resistant CRC cells lines 5.17
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 5.15
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 5.15
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.14
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.14
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 5.11
Dtx3L and Androgen Signaling in Prostate Cancer 5.1
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.1
Genome-wide discovery of human splicing branchpoints 5.09
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 5.09
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.05
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 5.01
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.97
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.97
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.9
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 4.86
In vitro modeling of human germ cell development using pluripotent stem cells 4.84
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 4.8
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 4.78
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.77
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 4.74
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 4.71
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 4.71
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 4.69
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 4.69
snRNAs as regulators of alternative splicing 4.68
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.67
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 4.66
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.62
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 4.6
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.6
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 4.6
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 4.6
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.59
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.59
Noncoding regions are the main source of targetable tumor-specific antigens 4.57
RNAseq Study in CC-671 Treated Cal-51 Cells 4.57
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.55
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 4.55
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 4.55
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.53
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 4.44
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.41
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.4
Effect of PRDM11 depletion in U2932 cells 4.38
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.38
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.38
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.35
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.35
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.34
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 4.34
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.32
RNA-seq differential expression studies: more sequence, or more replication? 4.29
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.28
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.28
Transcriptome of human ILC2s; primary vs IL-1b-primed 4.27
RNA-sequencing 4.25
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 4.24
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 4.23
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 4.23
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.22
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.19
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 4.18
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.15
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.15
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 4.14
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.1
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.09
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.04
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.94
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.9
RNA-seq analysis upon ARID1B overexpression 3.86
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.81
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.79
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 3.75
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.73
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 3.73
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 3.73
RNAseq of cell lines with knocked in ESR1 mutations 3.72
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 3.71
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.69
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.67
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.67
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.64
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.63
The transcriptome effect of overexpressing EZH2 in MCF7 3.63
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.61
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 3.57
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.56
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 3.52
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.52
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.52
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.52
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.48
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.46
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.41
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.41
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.36
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 3.29
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 3.29
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 3.24
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.23
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.23
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.22
CD74 role in transcription regulation [RNA-seq] 3.21
CD74 role in transcription regulation 3.21
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.13
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.11
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.08
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 3.06
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.03
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 3.01
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.99
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.94
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.94
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.84
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 2.84
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.82
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.81
An optimization system for isolating and sequencing of single human colon cancer cells 2.81
Effect of PBK knockdown on C4-2 cell transcriptome 2.79
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.78
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.78
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.77
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 2.76
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 2.75
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.72
Identification of global XBP1s target gene expression in human prostate cancer cells 2.68
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 2.68
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.66
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.62
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.59
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.59
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.58
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 2.56
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 2.56
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.55
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.52
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.5
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.44
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.44
The age and genomic integrity of neurons after cortical stroke in humans 2.37
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.36
Transcriptome analysis of BAP1 knockout and restoration 2.34
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 2.34
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.34
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.34
Gene expression analysis of human hepatocellular cancers 2.3
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.27
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.26
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.26
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.23
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 2.18
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.18
HNRNPM-regulated splicing dependencies in prostate cancer 2.18
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.12
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.12
quanTIseq: quantifying immune contexture of human tumors 2.08
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 2.03
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.03
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 2.03
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 2.0
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.0
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.99
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 1.94
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.92
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.86
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.85
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.84
The contribution of Alu exons to the human proteome 1.84
The cohesin release factor WAPL restricts chromatin loop extension. 1.81
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.81
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.78
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.78
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.77
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.76
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.76
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.74
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.71
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.69
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.69
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.67
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.55
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.55
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.51
Copper Regulation of HIF-1 Transcription Activity 1.5
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.5
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.5
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.49
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.47
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 1.46
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.45
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.45
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.45
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.45
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.43
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.4
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.4
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.36
Transcriptome analysis of CNS leukemia 1.36
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.33
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.32
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.28
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.26
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.25
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.24
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.24
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.23
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.23
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.23
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.23
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.2
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.19
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.17
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.13
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.13
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.1
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.09
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.09
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.09
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.06
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.05
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.05
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.04
Human Treg IFNg/IL-10 subpopulations 1.0
The circadian transcriptional landscape in primary human mammary epithelial cells 0.96
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.96
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.91
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.91
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.9
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.9
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.9
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.9
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.88
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 0.86
Interaction between mitoNEET and NAF-1 in cancer cells 0.85
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.81
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.79
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.79
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.77
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.76
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.7
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.64
naive T cell heterogeneity after neonatal thymectomy 0.64
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 0.64
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.55
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.55
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.54
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.53
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.52
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.51
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.5
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.5
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.49
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.49
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.48
Effects of transcription on genome - nuclear lamina interactions 0.48
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.46
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.46
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.46
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.46
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.46
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.44
Total RNA-Seq data from leukemic patients with complex structural variants 0.42
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.39
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.38
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 0.36
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.36
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.35
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.34
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.29
Gene expression changes after LOC550643 silencing 0.28
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.28
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.26
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.26
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.25
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.24
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.23
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.23
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.21
Aging-associated patterns in the expression of human endogenous retroviruses 0.19
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.18
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.15
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.14
Human ovarian granulosa cell transcriptome 0.13
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.12
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.11
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.11
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.11
A code of mono-phosphorylation modulates the function of RB. 0.11
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.1
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.1
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.08
Modulation of nonsense-mediated decay by rapamycin 0.02
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.01
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation